JPMorgan Chase & Co. Sells 80,515 Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)
JPMorgan Chase & Co. trimmed its stake in shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) by 33.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 163,113 shares of the biotechnology company’s stock after selling 80,515 shares […]
